PHP
CVRX icon

Parkman Healthcare Partners’s CVRx CVRX Stock Holding History

Parkman Healthcare Partners’s Portfolio CVRX Stock Details CVRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-429,507
Closed -$4.06M – 86
2026
Q1 		$4.06M Buy
429,507
+16,489
+4% +$121K 0.42% 66
2025
Q4 		$2.93M Sell
413,018
-78,390
-16% -$716K 0.28% 81
2025
Q3 		$3.97M Sell
491,408
-297,691
-38% -$2.24M 0.41% 70
2025
Q2 		$4.64M Sell
789,099
-440,423
-36% -$3.04M 0.53% 65
2025
Q1 		$15M Buy
1,229,522
+308,348
+33% +$4.35M 1.78% 19
2024
Q4 		$11.7M Buy
921,174
+238,277
+35% +$2.94M 1.55% 23
2024
Q3 		$6.02M Buy
682,897
+235,277
+53% +$2.14M 0.77% 45
2024
Q2 		$5.37M Buy
447,620
+115,530
+35% +$1.33M 0.72% 49
2024
Q1 		$6.05M Buy
332,090
+92,090
+38% +$2.18M 0.74% 47
2023
Q4 		$7.55M Buy
240,000
+17,880
+8% +$335K 1.06% 32
2023
Q3 		$3.37M Buy
222,120
+81,357
+58% +$1.34M 0.62% 47
2023
Q2 		$2.17M Buy
+140,763
New +$1.72M 0.38% 74

Other funds holding CVRX

JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Parkman Healthcare Partners's CVRX Position: Q2 2026 in Review

Parkman Healthcare Partners sold out of CVRx (CVRX) in Q2 2026, closing a stake of 429,507 shares — an estimated $4.06M sold.

Parkman Healthcare Partners first reported a position in CVRX in Q2 2023 and held it in 12 quarters. The position peaked at $15M in Q1 2025. 87 funds tracked by Wall St. Rank hold CVRX as of Q2 2026.

  • Parkman Healthcare Partners reported no remaining CVRx position as of Q2 2026 after selling out during the quarter.
  • Parkman Healthcare Partners sold 429,507 CVRx shares in Q2 2026, an estimated $4.06M.
  • Parkman Healthcare Partners first reported a position in CVRx in Q2 2023 and held it in 12 quarters.
  • Parkman Healthcare Partners's CVRx position peaked at $15M in Q1 2025.
  • 87 funds tracked by Wall St. Rank held CVRx as of Q2 2026.

Based on Parkman Healthcare Partners's 13F filing for Q2 2026, filed 14 Aug 2026.